1cP-AL-LAD
Summary
1-Cyclopropionyl-6-allyl-6-nor-lysergic acid diethylamide (also known commonly as 1cP-AL-LAD) is a novel psychedelic substance of the lysergamide class. 1cP-AL-LAD is closely related to AL-LAD, for which it is suspected to be a prodrug for, but there is currently no data or much anecdotal reports to confirm this. 1cP-AL-LAD is a novel research chemical which has probably first been produced by a small group of chemists which have also synthesized various other novel lysergamdîdes at the time alongside like 1cP-MiPLA, LSZ and LST in 2020 or 2021.
Perspectives
“1cP-AL-LAD gets a thumbs up from me, it’s a vivid visual experience, at once lucid but also surprisingly insightful and cognitive when thoughts are properly stimulated. I would argue from my personal experiences that the 1cP substitution lends itself to greater visuals in proportion to other psychedelic effects.”
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral / Sublingual (Blotter) | 50-100µg | 100-225µg | 225-350µg | 350µg+ |
| Oral | 50-100µg | 100-225µg | 225-350µg | 350µg+ |
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset |
|---|---|---|---|---|
| Oral / Sublingual (Blotter) | 20-60 min | 30-60 min | 2.5-5 hrs | 2-3 hrs |
| Insufflated (Liquid) | 15-30 min | 20-45 min | 2.5-5 hrs | 2-3 hrs |
| Oral | 18-60 min | 30-60 min | 2.5-5 hrs | 2-3 hrs |
Effect Profile
5 reportsScores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Strong visuals and auditory effects with moderate body load, mild headspace
Tolerance
Tolerance Decay
Estimates reflect classic psychedelic cross‑tolerance behavior; based on TripSit/community consensus for LSD. Avoid re‑dosing same day; it lengthens duration more than intensity.
Effects
Aggregated from 5 Erowid experience reports